FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3209538100> ?p ?o ?g. }

• W3209538100 endingPage "e597" @default.
• W3209538100 startingPage "e597" @default.
• W3209538100 abstract "RTOG 0424 demonstrated that high-risk low-grade glioma (LGG) patients treated with concurrent temozolomide (TMZ) and radiotherapy (RT) followed by adjuvant TMZ (RT+TMZ) had a survival longer than that reported for historical controls. The impact of this treatment strategy on short term neurocognitive outcomes is not well established. We sought to evaluate neurocognitive measures among adult LGG patients prior to and following RT+TMZ.We prospectively evaluated 22 LGG patients treated postoperatively with RT + TMZ. Neurocognitive batteries were administered pre- and post-treatment. Verbal (Hopkins Verbal Learning Test [HVLT]) and nonverbal (Brief Visuospatial Memory Test [BVMT]) learning and memory, motor functioning (Grooved Pegboard Test), and phonemic fluency (CFL) were assessed. Nonparametric paired t-test (Wilcoxon signed ranked test) was performed for paired samples, with post-treatment of within 3 months (14 pairs), and after 3 months (12 pairs) respectively. All the statistical analysis was performed with R 4.0.3.The median age at diagnosis was 43 years (range: 23-77), and 18 (82%) were male. By molecular classification, the cohort was comprised of IDHmut-1p19q-codel, IDHmut-1p19q-noncodel, IDHmut-NOS, IDH1-R132H-negative, and unknown, in 3 (14%) patients, 3 (14%), 1 (5%), 11 (50%), and 4 (18%), respectively. Gross total resection was obtained for 3 (14%) patients, near total resection for 2 (9%), subtotal resection for 6 (27%), and biopsy for 11 (50%). Patients did not show a significant decline within 3 months of receiving RT+TMZ in nonverbal learning (BVMT total recall, P = 0.67, n = 14) or in verbal learning or memory (HVLT, P = 0.06, n = 14). Similarly, nonverbal learning and verbal learning/memory measured ≥ 3 months from completing treatment showed no significant decline (P = 0.62, n = 12; P = 0.67, n = 12, respectively). Motor function (Grooved Pegboard, both dominant and non-dominant) remained stable within 3 months post-treatment (P = 0.84, n = 14; P = 0.26, n = 14) and after 3 months (P = 0.94, n = 12; P = 0.09, n = 12). Phonemic fluency (CFL) did not show a significant decline within 3 months post-treatment (P = 0.083, n = 14) or after 3 months (P = 0.67, n = 12).Adult LGG patients did not show subacute significant changes in verbal and nonverbal memory, motor function or phonemic fluency following RT+TMZ compared their pre-radiation baseline. A larger sample size and longer follow-up is necessary to identify the neurocognitive impact of this treatment approach.D.Y. Park: None. M.C. Tom: Research Grant; Blue Earth Diagnostics. Y. Chen: None. W. Wei: None. S. Tewari: None. M. Ahluwalia: Consultant; AbbVie, Bayer, VBI vaccines, Karyopharm, Elsevier. Stock; Mimivax, Doctible. J.S. Yu: None. S.T. Chao: Honoraria; Varian Medical Systems, Zeiss, AbbVie. Consultant; AbbVie. J.H. Suh: Consultant; Philips, Novocure. Met to discuss current indications for TTF; Novocure. Met during 1 day retreat to discuss future of radiation oncology; Philips. Scientific advisory board; Neutron Therapeutics. D. Peereboom: None. G. Stevens: None. G.H. Barnett: None. L. Angelov: None. A.M. Mohammadi: None. I. Katzan: None. T. Hogan: None. C. Kissel: None. B. Lapin: None. I. Schuermeyer: None. M.W. Parsons: None. R. Naugle: None. E.S. Murphy: None." @default.
• W3209538100 created "2021-11-08" @default.
• W3209538100 creator A5003799076 @default.
• W3209538100 creator A5007781476 @default.
• W3209538100 creator A5016811839 @default.
• W3209538100 creator A5017103994 @default.
• W3209538100 creator A5020314202 @default.
• W3209538100 creator A5022529347 @default.
• W3209538100 creator A5025474357 @default.
• W3209538100 creator A5027618976 @default.
• W3209538100 creator A5035416012 @default.
• W3209538100 creator A5035503064 @default.
• W3209538100 creator A5043287152 @default.
• W3209538100 creator A5045918267 @default.
• W3209538100 creator A5053904567 @default.
• W3209538100 creator A5054556041 @default.
• W3209538100 creator A5065263618 @default.
• W3209538100 creator A5069313574 @default.
• W3209538100 creator A5070144744 @default.
• W3209538100 creator A5073887492 @default.
• W3209538100 creator A5074816582 @default.
• W3209538100 creator A5076929703 @default.
• W3209538100 creator A5079216912 @default.
• W3209538100 creator A5079508350 @default.
• W3209538100 date "2021-11-01" @default.
• W3209538100 modified "2023-09-27" @default.
• W3209538100 title "Neurocognitive Function Following Concurrent Radiotherapy and Temozolomide for Adult Patients With Low-Grade Glioma" @default.
• W3209538100 doi "https://doi.org/10.1016/j.ijrobp.2021.07.1596" @default.
• W3209538100 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34701838" @default.
• W3209538100 hasPublicationYear "2021" @default.
• W3209538100 type Work @default.
• W3209538100 sameAs 3209538100 @default.
• W3209538100 citedByCount "0" @default.
• W3209538100 crossrefType "journal-article" @default.
• W3209538100 hasAuthorship W3209538100A5003799076 @default.
• W3209538100 hasAuthorship W3209538100A5007781476 @default.
• W3209538100 hasAuthorship W3209538100A5016811839 @default.
• W3209538100 hasAuthorship W3209538100A5017103994 @default.
• W3209538100 hasAuthorship W3209538100A5020314202 @default.
• W3209538100 hasAuthorship W3209538100A5022529347 @default.
• W3209538100 hasAuthorship W3209538100A5025474357 @default.
• W3209538100 hasAuthorship W3209538100A5027618976 @default.
• W3209538100 hasAuthorship W3209538100A5035416012 @default.
• W3209538100 hasAuthorship W3209538100A5035503064 @default.
• W3209538100 hasAuthorship W3209538100A5043287152 @default.
• W3209538100 hasAuthorship W3209538100A5045918267 @default.
• W3209538100 hasAuthorship W3209538100A5053904567 @default.
• W3209538100 hasAuthorship W3209538100A5054556041 @default.
• W3209538100 hasAuthorship W3209538100A5065263618 @default.
• W3209538100 hasAuthorship W3209538100A5069313574 @default.
• W3209538100 hasAuthorship W3209538100A5070144744 @default.
• W3209538100 hasAuthorship W3209538100A5073887492 @default.
• W3209538100 hasAuthorship W3209538100A5074816582 @default.
• W3209538100 hasAuthorship W3209538100A5076929703 @default.
• W3209538100 hasAuthorship W3209538100A5079216912 @default.
• W3209538100 hasAuthorship W3209538100A5079508350 @default.
• W3209538100 hasBestOaLocation W32095381001 @default.
• W3209538100 hasConcept C118552586 @default.
• W3209538100 hasConcept C126322002 @default.
• W3209538100 hasConcept C14216870 @default.
• W3209538100 hasConcept C143998085 @default.
• W3209538100 hasConcept C169900460 @default.
• W3209538100 hasConcept C172467417 @default.
• W3209538100 hasConcept C2777389519 @default.
• W3209538100 hasConcept C2778227246 @default.
• W3209538100 hasConcept C2994444459 @default.
• W3209538100 hasConcept C502942594 @default.
• W3209538100 hasConcept C509974204 @default.
• W3209538100 hasConcept C67761136 @default.
• W3209538100 hasConcept C71924100 @default.
• W3209538100 hasConcept C97530452 @default.
• W3209538100 hasConceptScore W3209538100C118552586 @default.
• W3209538100 hasConceptScore W3209538100C126322002 @default.
• W3209538100 hasConceptScore W3209538100C14216870 @default.
• W3209538100 hasConceptScore W3209538100C143998085 @default.
• W3209538100 hasConceptScore W3209538100C169900460 @default.
• W3209538100 hasConceptScore W3209538100C172467417 @default.
• W3209538100 hasConceptScore W3209538100C2777389519 @default.
• W3209538100 hasConceptScore W3209538100C2778227246 @default.
• W3209538100 hasConceptScore W3209538100C2994444459 @default.
• W3209538100 hasConceptScore W3209538100C502942594 @default.
• W3209538100 hasConceptScore W3209538100C509974204 @default.
• W3209538100 hasConceptScore W3209538100C67761136 @default.
• W3209538100 hasConceptScore W3209538100C71924100 @default.
• W3209538100 hasConceptScore W3209538100C97530452 @default.
• W3209538100 hasIssue "3" @default.
• W3209538100 hasLocation W32095381001 @default.
• W3209538100 hasLocation W32095381002 @default.
• W3209538100 hasOpenAccess W3209538100 @default.
• W3209538100 hasPrimaryLocation W32095381001 @default.
• W3209538100 hasRelatedWork W2041944042 @default.
• W3209538100 hasRelatedWork W2069418962 @default.
• W3209538100 hasRelatedWork W2154049325 @default.
• W3209538100 hasRelatedWork W2314179774 @default.
• W3209538100 hasRelatedWork W3028604776 @default.
• W3209538100 hasRelatedWork W3206432790 @default.
• W3209538100 hasRelatedWork W3209538100 @default.
• W3209538100 hasRelatedWork W4225117539 @default.

• next